Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Inhibikase Therapeutics, Inc.
IKT · Transcripts
website
35
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops ther...
Price
1.68
Market Cap
209.3 M
Float
111.9 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about IKT
Inhibikase Therapeutics, Inc.
IKT · Transcripts
111.9 M
Float
1.68
Price
209.3 M
Market Cap
2024
AI
Type
Title
Quarter
Created Date
2023
AI
Type
Title
Quarter
Created Date
2022
AI
Type
Title
Quarter
Created Date
2021
AI
Type
Title
Quarter
Created Date